Compare ABVC & BHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABVC | BHM |
|---|---|---|
| Founded | 2015 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6M | 35.7M |
| IPO Year | 2009 | 2022 |
| Metric | ABVC | BHM |
|---|---|---|
| Price | $0.87 | $9.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 101.5K | 3.1K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.54% |
| EPS Growth | ★ 7.14 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $509,589.00 | ★ $68,734,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 36.88 |
| 52 Week Low | $0.82 | $8.05 |
| 52 Week High | $3.39 | $13.59 |
| Indicator | ABVC | BHM |
|---|---|---|
| Relative Strength Index (RSI) | 37.11 | 53.69 |
| Support Level | N/A | $8.81 |
| Resistance Level | $1.14 | $9.02 |
| Average True Range (ATR) | 0.09 | 0.31 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 22.38 | 84.09 |
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.